Background {#Sec1}
==========

Many flavonoids have been recognized for their antitumor properties \[[@CR1]--[@CR4]\]. It is known that these activities are greatly determined by their chemical structure which subsequently dictates their ability to interact with cellular molecules \[[@CR1]\]. This differential effect has been observed with flavone isomers 5,7-dihydroxy-3,6,8-trimethoxy flavone (flavone A) and 3,5-dihydroxy-6,7,8-trimethoxy flavone (flavone B) \[[@CR5]\]. Specifically, each isomer has been shown to target colon cancer cells with distinct phenotypical characteristics via different mechanisms of action \[[@CR6]\]. However, it is unknown whether either of these flavones distribute to the colon after intravenous administration of these compounds. Modifications were made to methods developed for extracting and quantifying these flavones in rat plasma \[[@CR7]\] using reverse phase high performance liquid chromatography (HPLC). The modifications included preparation of the sample by homogenization in water, filtration using a polyvinylidene fluoride (PVDF) membrane, and the creation of a single calibration curve to determine the concentration of either flavone in colon tissue.

These methods allowed for the detection of flavone A and flavone B in rat colon. Our data indicate that flavone B was found in higher concentrations in the colon than flavone A, which may be the result of higher volume of distribution value of flavone B \[[@CR7]\] compared to that of flavone A.

Methods {#Sec2}
=======

Procedure to extract and purify flavones A and B {#Sec3}
------------------------------------------------

The compounds were obtained as described before \[[@CR5]\]. Briefly, flavone A was purified from dried flowers of *Gnaphalium elegans* extracted with chloroform using a silica gel chromatography column. Flavone B was purified from leaves of *Achyrocline bogotensis*, using chloroform, followed by crystallizations in hexane. The physical and spectroscopic properties of these compounds allowed their proper identification.

Stock solution and standards {#Sec4}
----------------------------

Stock solutions of flavone A at a concentration of 100 µg/mL, prepared as described previously \[[@CR7]\], and 25 µg/mL celecoxib (Toronto Research Chemicals; Toronto, ON, CA) were prepared with acetonitrile/water/acetic acid/triethylamine (60:40:0.2:0.05). Stock solutions of 100 µg/mL of flavone B, prepared as described previously \[[@CR7]\], and 25 µg/mL diclofenac (MP Biomedicals, LLC; Solon, OH) were prepared with acetonitrile/water/acetic acid/trimethylamine (70:30:0.2:0.05). All stock solutions were stored protected from light at 4 °C. HPLC grade acetonitrile, acetic acid, trimethylamine, and water were purchased from Fisher Scientific (Pittsburgh, PA). Flavone A or flavone B were mixed with polyethylene glycol 400 (Electron Microscopy Sciences; Hatfield, PA) for intravenous injection.

Sample preparation {#Sec5}
------------------

Colon tissue was homogenized using a PowerGen 700 from Fisher Scientific (Pittsburgh, PA) in a 1:2 ratio with water (1 mg/2 mL). Serial concentrations for calibration curves (flavone A: 250--100,000 ng/g and flavone B: 1000--25,000 ng/g) were prepared. Briefly, 100 μL of blank homogenate was spiked with 100 μL flavone, 100 µL internal standard (25 µg/mL celecoxib or diclofenac), and 200 μL of organic solvent (acetonitrile). The samples were vortex mixed before being centrifuged for 15 min at 3000×*g*. The supernatant was removed and filtered with a PDVF filter (0.45 µm) into a clean tube and evaporated using a Labconco vacuum concentrator (Kansas City, MO). Mobile phase (200 μL) was used to reconstitute the residue and 100 μL of sample was injected into the HPLC column. Analysis was conducted in triplicate.

HPLC conditions and quantitation {#Sec6}
--------------------------------

HPLC assays were performed using a Shimadzu liquid chromatography system (Shimadzu Scientific Instruments Inc., Columbia, Maryland, USA) with an ACE C18 (100 × 4.6 mm) (Aberdeen, Scotland) column. Mobile phases used for HPLC contained acetonitrile/water 60:40 (flavone A) and 70:30 (flavone B) with 0.2% acetic acid and 0.05% triethylamine. Detection wavelength was at 245 nm with a temperature of 30 °C. Flow rate was 0.4 mL/min with run times of 11 and 10 min, respectively. LC solutions program was used to collect and analyze the data.

Animals and drug administration {#Sec7}
-------------------------------

The methods described here were used to determine the concentrations of flavone A or flavone B in colon tissue collected from male Sprague--Dawley rats (Charles River Laboratories, Raleigh, NC, USA) used in a previous study \[[@CR7]\]. Briefly, flavones were mixed in polyethylene glycol 400 and were administered by intravenous injection to deliver a 20 mg/kg dose of flavone A (n = 6) or flavone B (n = 6). Animals were euthanized under anesthesia 6 h post dosing. Colon tissue was collected and flash frozen using dry ice and stored at −80 °C until analyzed for the measurement of concentrations of flavones.

Results {#Sec8}
=======

Good separation was achieved (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}) and the peak area ratios of flavone against internal standard were plotted in Excel to make the calibration curves (Fig. [3](#Fig3){ref-type="fig"}). Representative equation for flavone A concentrations 250--100,000 ng/g was y = 2E − 05x + 0.0029 and flavone B concentrations 1000--25,000 ng/g was y = 7E − 05x + 0.0531 with *r* ^*2*^ ≥ 0.99. Three calibration curves were used to determine the precision (coefficient of variation---CV) and accuracy of the methods. Data is presented as mean ± standard deviation (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}). Analysis yielded 1639 ± 601 ng/g of flavone A and 5975 ± 2480 ng/g of flavone B in colon tissue (Fig. [4](#Fig4){ref-type="fig"}).Fig. 1Elution of flavone A from colon. HPLC chromatographs of **a** blank colon; **b** colon spiked with internal standard (celecoxib 25 µg/mL); **c** colon spiked with flavone A (100 µg/mL) and internal standard Fig. 2Elution of flavone B from colon. HPLC chromatographs of **a** blank colon; **b** colon spiked with internal standard (diclofenac 25 µg/mL); **c** colon spiked with flavone B (100 µg/mL) and internal standard Fig. 3Calibration curves were made by graphing the ratio of flavone/internal standard area under the curve extracted from colon tissue versus the known concentration of flavone. Representative calibration curves for **a** flavone A and **b** flavone B are presented Table 1Precision and accuracy for 250--100,000 ng/g flavone A extracted from rat colon tissueConcentration (ng/g)Error (%)Observed (n = 3)CVAccuracy (%)100,00013.88 ± 2.14113,888 ± 21381.8711425,00016.32 ± 1.0629,081 ± 2650.9111610,00011.83 ± 4.1511,182 ± 4153.7111150009.93 ± 0.975496 ± 480.88109250013.92 ± 4.872848 ± 1214.27113100011.45 ± 8.901114 ± 897.9811150016.65 ± 21.51558 ± 12923.2111125021.02 ± 19.30285 ± 6824.03113 Table 2Precision and accuracy for 1000--25,000 ng/g flavone B extracted from rat colon tissueConcentration (ng/g)Error (%)Observed (n = 3)CVAccuracy (%)25,0001.51 ± 0.5025,204 ± 4101.6210110,0002.89 ± 0.5210,075 ± 3453.4310150003.69 ± 3.424934 ± 2715.519825004.22 ± 2.552480 ± 1425.7399100025.18 ± 27.001128 ± 37833.56113 Fig. 4Distribution of flavones to target tissue. Male Sprague--Dawley rats received 20 mg/kg of either flavone A or flavone B via intravenous injection. The colon tissues were collected 6 h after dosing and analyzed for the presence of flavone using a HPLC system

Conclusion {#Sec9}
==========

Modifications to the methods developed for extraction and quantification of flavone A and flavone B from rat colon tissue yield good separation, precision, and accuracy. The distribution of both flavones to the colon suggests that they would be good candidates for in vivo antitumor studies for colon cancer.
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